Search Tag: Cynosure

IMAGING Management

Hologic-receives-ce-mark-to-market-sculpsure-r-for-non-invasive-body-contouring-of-the-submental-area

2017 19 Oct

Patients in Clinical Studies Report 100% Satisfaction Hologic, Inc. has announced that it has received an additional European Medical Device Directive (MDD) certification for SculpSure®, a state-of-the-art body contouring laser treatment. The device is now certified to treat a double chin (also known as the submental area), marking the product's...Read more

IMAGING Management

Hologic-receives-fda-510-k-clearance-to-market-sculpsure-r-for-non-invasive-body-contouring

2017 30 Sep

Patients in Clinical Studies Report 100% Satisfaction Rate   Hologic, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted an expanded FDA 510(k) clearance for Cynosure's non-invasive body contouring product,  SculpSure ®. The state-of-the-art body contouring laser treatment is now cleared to treat a double chin (also...Read more

IMAGING Management

Hologic-receives-expanded-fda-510-k-clearance-to-market-cynosure-s-sculpsure-r

2017 16 Jun

SculpSure Now Cleared to Treat Five Areas of the Body Hologic, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted an expanded clearance for Cynosure's non-invasive body contouring product,  SculpSure , to treat the back and inner and outer thighs. The SculpSure treatment is already FDA-cleared for treatment of...Read more

IMAGING Management

Hologic-to-acquire-cynosure-in-all-cash-tender-offer-that-combines-two-complementary-businesses

2017 14 Feb

-Expands Hologic's Scientific and Commercial Expertise into Large, Adjacent Medical Device Segment Growing at Double-Digit Rate  -Accelerates Hologic's Top- and Bottom-Line Growth Rates and is Immediately Accretive to Non-GAAP Earnings per Share  \ Hologic, Inc., a leader in women's health, and Cynosure, Inc. (Nasdaq: CYNO), a leader in medical...Read more